How dangerous are errant nanoparticles? New imaging technology aims to find out

Sometimes it’s the small things that cause the biggest problems.

As modern manufacturing, consumer products and industrial processes continue to utilize the rapidly evolving science of nanotechnology, identifying and studying the possible adverse effects of nanoparticle exposure is vital to ensuring the health and safety of consumers, industry workers and the environment.

Luckily, researchers from the SUNY Polytcechnic Institute in Utica, N.Y., have developed a new imaging method to visualize and identify engineered nanoparticles in biological tissue, providing an inexpensive tool for nanomaterial analysis.

The process utilizes a newly created low-volume Franz chamber system that enables miniscule amounts of nanometal oxides to be used in detecting tissue penetration.

Read more about the innovative imaging research at the link below.

 

 

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.